Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 766Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Causality assessment: A brief insight into practices in pharmaceutical industry

Naidu R Purushotham

Year : 2013| Volume: 4| Issue : 4 | Page no: 233-236

   This article has been cited by
1 Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
Juliana Hey-Hadavi,Daniel Seekins,Melissa Palmer,Denise Coffey,John Caminis,Sandzhar Abdullaev,Meenal Patwardhan,Haifa Tyler,Ritu Raheja,Ann Marie Stanley,Liliam Pineda-Salgado,David L. Bourdet,Raul J. Andrade,Paul H. Hayashi,Lara Dimick-Santos,Don C. Rockey,Alvin Estilo
Drug Safety. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy
Jyoti Bhagatram Sharma, Manjunath Nookala Krishnamurthy, Ankita Awase, Amit Joshi, Vijay Patil, Vanita Noronha, Kumar Prabhash, Vikram Gota
Therapeutic Advances in Drug Safety. 2021; 12: 2042098621
[Pubmed]  [Google Scholar] [DOI]
3 The Food and Drug Administration Biologics Effectiveness and Safety Initiative Facilitates Detection of Vaccine Administrations From Unstructured Data in Medical Records Through Natural Language Processing
Matthew Deady, Hussein Ezzeldin, Kerry Cook, Douglas Billings, Jeno Pizarro, Amalia A. Plotogea, Patrick Saunders-Hastings, Artur Belov, Barbee I. Whitaker, Steven A. Anderson
Frontiers in Digital Health. 2021; 3
[Pubmed]  [Google Scholar] [DOI]
4 Overview of important methods used for causality assessment of adverse drug events in pharmacovigilance
Pushpraj Prafulla Gawai 
Journal of Pharmacovigilance and Drug Research. 2020; 1(2): 6
[Pubmed]  [Google Scholar] [DOI]
5 A Rare Case of Flavocoxid-Induced Pulmonary Fibrosis
Dimitrios Drekolias,Naga Vaishnavi Gadela,Philip Krupka,Jennifer Broess,Jason Jacob
Cureus. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System
Ji Sun,Xuanyu Deng,Xiaoping Chen,Juanjuan Huang,Siqiong Huang,Yanfei Li,Jinhui Feng,Jiyang Liu,Gefei He
Clinical Pharmacology & Therapeutics. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Suspected Adverse Drug Reactions From Corticosteroids: Analysis of Reported Notifications to the Portuguese Pharmacovigilance System
Cristel Gonçalves,Cristina Monteiro,Jorge Luiz Santos
The Journal of Clinical Pharmacology. 2020;
[Pubmed]  [Google Scholar] [DOI]
8 Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia
H.S. Marshall,A.P. Koehler,B. Wang,M. AæHoure,M. Gold,H. Quinn,N. Crawford,N. Pratt,T.R. Sullivan,K. Macartney
Vaccine. 2020; 38(37): 5914
[Pubmed]  [Google Scholar] [DOI]
9 Oxacillin-induced leukocytoclastic vasculitis
Meric Mericliler,Andrew Moraco
IDCases. 2019; : e00539
[Pubmed]  [Google Scholar] [DOI]
10 The role of general practitioner in the study of adverse drug reactions epidemiology in ambulatory care setting
Turabian JL
Archives of Community Medicine and Public Health. 2019; : 003
[Pubmed]  [Google Scholar] [DOI]
11 Complementing Observational Signals with Literature-Derived Distributed Representations for Post-Marketing Drug Surveillance
Justin Mower,Trevor Cohen,Devika Subramanian
Drug Safety. 2019;
[Pubmed]  [Google Scholar] [DOI]
12 Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy
Bushra Weidenbusch,Günther H.S. Richter,Marie Sophie Kesper,Monika Guggemoos,Katja Gall,Carolin Prexler,Ilya Kazantsev,Alexandra Sipol,Lars Lindner,Michaela Nathrath,Olaf Witt,Katja Specht,Frigga Beitinger,Carolin Knebel,Stuart Hosie,Rüdiger von Eisenhardt-Rothe,Wilko Weichert,Irene Teichert-von Luettichau,Stefan Burdach
Oncotarget. 2018; 9(29): 20747
[Pubmed]  [Google Scholar] [DOI]
13 Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications
Justin Mower,Devika Subramanian,Trevor Cohen
Journal of the American Medical Informatics Association. 2018;
[Pubmed]  [Google Scholar] [DOI]
14 Comparison of different methods for causality assessment of adverse drug reactions
Sapan Kumar Behera,Saibal Das,Alphienes Stanley Xavier,Srinivas Velupula,Selvarajan Sandhiya
International Journal of Clinical Pharmacy. 2018;
[Pubmed]  [Google Scholar] [DOI]
15 Severe skin rash associated with efavirenz and atazanavir: a case report in a rural health facility in Kenya
K. Irungu
Drugs & Therapy Perspectives. 2018;
[Pubmed]  [Google Scholar] [DOI]
16 Adverse drug reactions in high-risk pregnant women: A prospective study
Alfredo Dias de Oliveira-Filho,Antonio Emanuel Soares Vieira,Roberta Cruz da Silva,Sabrina Joany Felizardo Neves,Thiago Antonio Barros Gama,Ryane Vieira Lima,Wlisses Ramon Oliveira,Júlia Maria de Gonçalves Dias
Saudi Pharmaceutical Journal. 2017;
[Pubmed]  [Google Scholar] [DOI]
17 Comparing Methods for Estimating Direct Costs of Adverse Drug Events
Hanna Gyllensten,Anna K. Jönsson,Katja M. Hakkarainen,Staffan Svensson,Staffan Hägg,Clas Rehnberg
Value in Health. 2017;
[Pubmed]  [Google Scholar] [DOI]
18 Linezolid induced optic neuropathy, a serious yet reversible adverse effect: a case report
Ritesh Shah,Samir Lamichhane
European Journal of Medical Case Reports. 2017; : 114
[Pubmed]  [Google Scholar] [DOI]
19 Household medical waste disposal policy in Israel
Zohar Barnett-Itzhaki,Tamar Berman,Itamar Grotto,Eyal Schwartzberg
Israel Journal of Health Policy Research. 2016; 5(1)
[Pubmed]  [Google Scholar] [DOI]
20 Polyarteritis nodosa. Diagnostic challenges in a patient with cutaneous vasculitis, psoriasis, psoriatic arthritis and pancytopenia: fatal progression after treatment with G-CSF
Paresh Jobanputra
Oxford Medical Case Reports. 2016; 2016(4): 86
[Pubmed]  [Google Scholar] [DOI]
21 Safety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspective
Shashidhar Swamy,Meenakshi Mourya,Ganesh Kadhe,Amey Mane,Sandesh Sawant
Expert Opinion on Drug Safety. 2015; 14(9): 1409
[Pubmed]  [Google Scholar] [DOI]
22 Adverse drug reactions in neonates: could we be documenting more?
Daniel B Hawcutt,Olya O’Connor,Mark A Turner
Expert Review of Clinical Pharmacology. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article